DUOX1 and metastatic malignant neoplasm: Epithelial-mesenchymal transition (EMT) is a key feature of aggressive and metastatic cancers, and the loss of DUOX1 is associated with a decrease in the epithelial marker E-cadherin, indicating that DUOX1 is closely associated with EMT (Little et al., 2016).